Abstract:OBJECTIVE To investigate the serum level of free fatty acid (FFA) and explore its relationship with cytokines and atherosclerosis (AS) in chronic kidney disease (CKD). METHODS The serum level of FFA was determined with enzymatic colorimetry. IL-1β, IL-6 and TNFα were determined with ELISA. High-sensitivity C-reactive protein (hsCRP) was measured with immunoturbidimetry. Prevalence of atherosclerosis was detected with carotid ultrasonography. We evaluated the relationship between serum levels of FFA and IL-1β, IL-6, TNFα, hsCRP as well as the renal function in 130 adult patients with CKD, stratified according to the GFR (based on the National Kidney Foundation/Kidney Dialysis Outcomes Quality Initiatives) and in 58 hemodialytic (HD) patients. The relationship between FFA level and cardiac geometry incidence in CKD patients was analyzed with logistic regression model. RESULTS The serum level of FFA was significantly higher in CKD patients as compared with that in the healthy controls [(492.63±143.59) vs (302.65±142.18) µmol/L, P<0.01], even in the early stage of CKD. The level of FFA increased with the progression of renal dysfunction. In the non-dialytic CKD group, the level of FFA was negatively related to GFR and positively related to the proteinuria (P<0.05), while in the HD group, it was positively correlated with dialysis duration (P<0.05). The serum levels of FFA were higher in CKD patients with carotid artery atherosclerosis than those in patients without (P<0.05or<0.01). However, in both groups with impairment of renal function, the levels of FFA were positively correlated with hsCRP, IL-1β, IL-6, TNFα and TG (all P<0.05). A positive correlation between the level of FFA and the clinical manifestations such as carotid intimal medial thickness (IMT) and AS was also found. A negative correlation was found between the level of FFA and the serum level of albumin and GFR (P<0.05). CONCLUSION Serum levels of FFA are significantly higher either in non-dialytic CKD or in HD patients and it is related with hsCRP, IL-1β, IL-6, TNFα as well as carotid artery atherosclerosis, indicating that FFA is an independent risk factor of AS in CKD.

The Level and Significance of Serum IL-6,TNF-α and L-carnitine in Hemodialysis Patients

The relationship between serum ceruloplasmin and iron deficiency,inflammation and peroxidation in hemodialysis patients

To Investigate Plasma Levels of Free and Total Carnitine in Patients Undergoing Hemodialysis or Peritoneal Dialysis

Relationship Between Soluble Receptor of Advanced Glycation End Product and Carotid Atherosclerosis in Patients under Hemodialysis

Association of Serum L-kynurenine with Nutritional Status and Vascular Stiffness in Maintenance Hemodialysis Patients

The Research of Carotid Atherosclerosis and Its Relative Factors of Hemodialysis Patients

Effect of l -carnitine therapy on patients in maintenance hemodialysis: a systematic review and meta-analysis

Exploring the relation between Interleukin-6 and high-sensitive cardiac troponin T in asymptomatic hemodialysis patient: A cross-sectional study

Relation between Pulmonary Function and Inflammatory Biomarkers in Hemodialysis Patients

Microinflammation associated with dyslipidemia and nutritional status in maintenance hemodialysis patients

Relationship of Serum Cystatin C Level with Cytokines and Carotid Atherosclerosis in Mintenance Hemodialysis Patients

Relationship between serum C-reactive protein levels and serum nutrition parameters, blood lipids or heart function in patients undergoing maintenance hemodialysis

Level of inflammatory factors in chronic hemodialysis patients with and without cardiovascular disease

Serum Lipoprotein-(A) Levels in Maintenance Hemodialysis-Patients

Relationship between plasma levels of zonulin, bacterial lipopolysaccharides, D-lactate and markers of inflammation in haemodialysis patients

[Relationship Between Serum Free Fatty Acid and Cytokines, Carotid Atherosclerosis in Chronic Kidney Disease].

Changes of Serum Lipoprotein(a) and Inflammatory Markers in Patients with Hemodialysis

Effects of Levocarnitine on Microinflammatory Status in Maintenance Hemodialysis Patients

The Clinical Analysis of L - Carnitine on Maintenance Hemodialysis Patient

Relation between Microinflammatory and Lipoprotein(α) in Maintained Hemodialysis Patients with Atherosclerosis

Serum High Sensitive C-reactive Protein Level Correlates with Cardiac Structure and Function in Patients Maintained on Hemodialysis